Skip to content
healthcare.dev

Enhertu

NDC 65597-406, fam-trastuzumab deruxtecan-nxki, injection, powder, lyophilized, for solution, from Daiichi Sankyo Inc..

Product NDC
65597-406
Status
Listed
Labeler
Daiichi Sankyo Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761139
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65597-406 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TRASTUZUMAB DERUXTECAN100 mg/5mL
Package NDCNDC-11Package
65597-406-01655970406011 VIAL, SINGLE-DOSE in 1 CARTON (65597-406-01) / 5 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7e67e73e-ddf4-4e4d-8b50-09d7514910b6
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=65597-406

Use it

Look up 65597-406 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65597-406 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65597-406. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.